期刊文献+

胃癌患者血清survivin抗体和胃泌素水平变化及意义 被引量:7

下载PDF
导出
摘要 目的观察胃癌患者血清survivin抗体和胃泌素水平变化,并探讨其临床意义。方法采用ELISA法检测70例胃癌患者(胃癌组)及20例健康体检者(对照组)血清survivin抗体和胃泌素水平,分析二者的关系及其与胃癌临床病理参数的关系。结果胃癌组血清中survivin抗体和胃泌素水平均高于对照组(P均<0.05);血清胃泌素水平与与胃肿瘤的淋巴结转移、分化程度、临床病理分期及肿瘤部位有关(P均<0.05),血清survivin抗体水平与肿瘤淋巴结转移、分化程度、临床病理分期有关(P均<0.05)。胃癌患者血清中survivin抗体和胃泌素水平呈正相关(r=0.665,P<0.05)。结论胃癌患者血清survivin抗体和胃泌素水平增高,二者与胃癌的发生、发展密切相关,联合检测有助于胃癌病情及预后的判断。
作者 胡华 金建军
出处 《山东医药》 CAS 2013年第8期45-46,共2页 Shandong Medical Journal
  • 相关文献

参考文献6

  • 1Baldwin GS. The role of gastfin and eholecystokin in normal and neoplastic gastrointestinal growth [ J]. J Gastroenterol hepatol, 1995,10 (2) :215.
  • 2Hino R, Uozaki H,lnoue Y, et al. Survival advantage of EBV-as-sociated gastric carcinoma: survivin up-regulation by viral latentmem- brane pretein 2A [ J]. Cancer Res, 2008,68 (5) :1427-1435.
  • 3Jahr S, Hentze H, Engliseh S, et al. DNA fragments in theblood plasma of ca/ice/patients:quantitations and evidencefor their origin from apoptotic and necrotic cells [ J]. Cancer Res, 2001,61 (4) : 1659-1665.
  • 4Rocker M, Henihan R J, Rosewicz S, et al. Gastrin and phor-bol 12-myristate 13-acetate regulate the human histidine decarboxy-lase promoter through ras-dependent activation of extracellular signal-regulated kinase-related signaling pathways in gastric cancer [ J ]. J Biol Chem, 1997, (272) :2840.
  • 5赵军,王宝中,张丽华,王彦文,韩慧.晚期结直肠癌患者血清抗Survivin抗体和血管内皮生长因子表达及其相关性[J].肿瘤研究与临床,2010,22(12):855-856. 被引量:5
  • 6吴安任.早期及进展期胃癌患者生存素与存活期的相关性分析[J].国际医药卫生导报,2009,15(13):24-26. 被引量:3

二级参考文献15

  • 1胡国洪,何耀武.胃癌分化程度、淋巴结转移和Hp感染与Bcl-2基因表达的关系[J].国际医药卫生导报,2006,12(14):11-12. 被引量:3
  • 2Lens SM, Vader G, Medema RH. The case for Survivin as mitotic regulator[J].Curr Opin Cell Biol, 2006, 18(6): 616-622.
  • 3Nakamura M, Tsuji N, Asanuma K, et al. Survivin as a predictor of cis-diamminedichloroplatinum sensitivity in gastric cancer patients[J]. Caner Sci, 2004, 95(1):44- 51.
  • 4Meng H, Tanigawa N, Hao CY, et al. Chemoresponse to docetaxel correlates with expression of the survivin splicing variants in patients with gastric cancer[J].Hepatogastronenterology, 2007, 54(79):1934-1940.
  • 5Capalbo G, Rodel C, Stauber RH, et al. The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target.[J]. Strahlenther Onkol, 2007, 183(11):593-599.
  • 6Lee JC,Chow NM,Wang ST,et al.Prognostic value of vascular Endothelial growth factor expression in colorectal cancer patients.Eur J Cancer,2000,36:748-752.
  • 7O'Connor DS,Schechner JS,Adida C,et al.Control of apoptosis during angiogenesis by survivin expression in endothelial cells.Am J Pathol,2000,156:393-346.
  • 8Kawasaki H,Toyoda M,Shinohara H,et al.Expression of survivin correlates with apoptosis,proliferation,and angiogenesis during human colorectal tumorigenesis.Cancer,2001,91:2026-2033.
  • 9Schmitz M,Diestelkoetter P,Weigle B,et al.Generation of survivinspecific CD+8 T effector cells by dendritic cells pulsed with protein or selected peptides.Cancer Res,2000,60:4845-4849.
  • 10Rohayem J,Diestelkoetter P,Weigle B,et al.Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients.Cancer Res,2000,60:1815-1817.

共引文献6

同被引文献110

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部